Skip to content

Clinical trials

Observational Immunoblastic Lymphadenopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Observational Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20082
20093
20101
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNC Lineberger Comprehensive Cancer Center2
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Columbia University1
Mayo Clinic1
Memorial Sloan Kettering Cancer Center1
Northwestern University1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
University of Nebraska1
Vanderbilt University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy12
Lymphoma, Large-Cell, Anaplastic12
Burkitt Lymphoma11
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular11
Lymphoma, Large B-Cell, Diffuse11
Lymphoma, Mantle-Cell11
Lymphoma, T-Cell, Cutaneous11
Mycosis Fungoides11

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.